Ah-young Oh

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Journal: Communications biology

Published: June 27, 2026

The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.

The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.

Journal: Molecular therapy. Oncology

Published: June 03, 2024

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Journal: Communications biology

Published: March 03, 2021

Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.

Journal: Communications biology

Published: February 12, 2020

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.

Journal: Leukemia

Published: September 16, 2018

p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation.

p53 induces senescence through Lamin A/C stabilization-mediated nuclear deformation.

Journal: Cell death & disease

Published: July 11, 2018

Loss of NF2 Induces TGFβ Receptor 1-mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome.

Loss of NF2 Induces TGFβ Receptor 1-mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome.

Journal: Molecular cancer therapeutics

Published: December 11, 2017

Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant Cancers.

Therapeutic Effect of Quinacrine, an Antiprotozoan Drug, by Selective Suppression of p-CHK1/2 in p53-Negative Malignant Cancers.

Journal: Molecular cancer research : MCR

Published: September 14, 2017

Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia.

Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia.

Journal: Scientific reports

Published: March 02, 2016

Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification.

Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification.

Journal: Oncotarget

Published: October 06, 2015

Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.

Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.

Journal: The Journal of clinical investigation

Published: August 10, 2015

Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.

Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.

Journal: Cancer research

Published: April 21, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026